10:44 AM EST - Abattis Bioceuticals Corp. : Announced that it has entered into an investment agreement to acquire a 49% stake in CannaNUMUS Blockchain Inc. CannaNUMUS is developing a cryptocurrency under which tokens will represent the performance of a suite of portfolio cannabis companies. Pursuant to the Agreement, in exchange for a 49% equity stake in CannaNUMUS, Abattis will make an initial cash payment of $5 million as well as milestone-based payments to CannaNUMUS of up to $7 million. Abattis Bioceuticals Corp.
shares ATT:CNX are trading off 3 cents at $0.49.
